Med24
Medical Research 28. 10. 2026 • 2 min read • News Medical

Michigan Medicine study reveals how diabetes drug reduces stroke risk

For millions living with type 2 diabetes, heart disease remains one of the greatest threats to their health.

Michigan Medicine study reveals how diabetes drug reduces stroke risk

Researchers at Michigan Medicine have identified a mechanism by which sotagliflozin, an FDA-approved diabetes medication, reduces the risk of heart attack and stroke. Laboratory experiments revealed that the drug prevents excessive platelet activation, a process leading to dangerous blood clots. Sotagliflozin, a sodium-glucose cotransporter (SGLT) inhibitor, targets both SGLT1 and SGLT2 proteins, differing from primarily SGLT2 inhibitors like empagliflozin (Jardiance). Comparisons showed sotagliflozin limited platelet activation in blood samples, while empagliflozin had minimal effect. In mice with injured blood vessels, sotagliflozin reduced clot formation by approximately 60%, compared to 5-10% with empagliflozin. Researchers found that removing SGLT1 from platelets reduced clot formation by about 40%, but this did not fully replicate sotagliflozin’s effects. They hypothesize that SGLT1 in endothelial cells may also influence platelet interactions. The drug’s unique effect suggests additional mechanisms beyond SGLT1 inhibition may contribute to its anti-clotting properties. This research indicates sotagliflozin may offer protection against blood clots, potentially lowering the risk of heart attack and stroke. The drug is currently approved for use in adults with heart failure, type 2 diabetes, chronic kidney disease, and other cardiovascular risk factors.

Sponsored content

Original Scientific Source
News Medical
View Original Source
Medical Disclaimer All calculations, recommendations, and interpretations provided by this tool are for informational and educational purposes only. They do not substitute professional medical advice, diagnosis, or treatment. Always consult your physician regarding any health concerns.

Recommended Medical News

All news →
Advertisement